Investec savages Aviva over potentially irreversible decline

Big losses see Amazons shares hit 12-month low

Investec Bank has issued a no-holds barred research note on Aviva and suggested that the provider may be in permanent decline as it cut the insurer’s target share price from 422p to 316p and advised investors to reduce their holdings.

Under the heading of "Recovery may not occur" analyst Kevin Ryan summed-up: "In our view, halting the shrinkage of Aviva's earnings, assets and dividends has now reached a critical stage. We are not sure if the decline can be reversed."

Clearly wrong
In the research note, which tackled all parts of Aviva, including both general and life insurance, the bank accepted that it was formerly a supporter of Aviva and had previously suggested the company could return to pre-eminence but that the title of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Polaris at 30 – Ray Vincent

As insurance industry owned Polaris celebrates its 30th birthday, Insurance Age asks experts for their recollections on the dawn of digital trading and what is coming next.

Meet the MGA: Kayzen Specialty

Kayzen Specialty founder and CEO Charles Boorman explains to Jonathan Swift his plans for the MGA to be a go-to market for financial lines through continuous improvement across its three pillars of broker-centric, underwriter-fronted and tech-focused.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: